Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
about
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis.
P2860
Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Calprotectin (S100A8/A9) and S ...... ritis treated with infliximab.
@en
type
label
Calprotectin (S100A8/A9) and S ...... ritis treated with infliximab.
@en
prefLabel
Calprotectin (S100A8/A9) and S ...... ritis treated with infliximab.
@en
P2093
P2860
P1476
Calprotectin (S100A8/A9) and S ...... ritis treated with infliximab.
@en
P2093
P2860
P304
P356
10.3109/03009742.2015.1107128
P577
2016-01-15T00:00:00Z